Opinion on cannabis as a legitimate healthcare solution Japan 2024

Published by
Catharina Klein,
Dec 9, 2024

According to a survey conducted in Japan in July 2024, 57 percent of respondents reported that they did not view cannabis as a legitimate healthcare solution. Following that, 32 percent of respondents answered that they were unsure about it.

Opinion on cannabis as a legitimate healthcare solution in Japan as of July 2024

© Statista 2024
Download
Show detailed source information?
Register for free
Already a member?
Log in
Source

Use Ask Statista Research Service

Release date

July 2024

Region

Japan, APAC

Survey time period

July 2 to 14, 2024

Number of respondents

3,099 respondents

Age group

16-80 years

Supplementary notes

Original survey question: "Which of the following statements regarding health and wellness do you agree or disagree with? I see cannabis as a legitimate healthcare solution."

Citation formats
Access all statistics starting from $2,388 USD yearly *

* For commercial use only

Basic Account

For single users
$0 USD
Always free
Access limited to Free Statistics. Premium Statistics are not included.
  • Free Statistics
Based on your interests

Starter Account

For single users
$199 USD
per month, billed annually 1
Buy now
  • Free Statistics
  • Premium Statistics

    • The statistic on this page is a Premium Statistic and is included in this account.

Professional Account

For teams of up to 5 people
$959 USD
per month, billed annually 1
Buy now
  • Free + Premium Statistics
  • Reports
  • Market Insights

1 All prices do not include sales tax. The account requires an annual contract and will renew after one year to the regular list price.

Compare accounts

Statistics on " Medical cannabis in the U.S. "

The most important statistics
The most important statistics
The most important statistics
The most important statistics
The most important statistics
The most important statistics

Other statistics that may interest you Medical cannabis in the U.S.

Overview

8

Companies

5

Cannabidiol

5

Focus: Colorado

6

Focus: Oregon

5

Patients and opinions

4

Further Content: You might find this interesting as well

Topics

Medical cannabis in the U.S.Global pharmaceutical industryRecreational cannabis in the United StatesCancer in the U.S.Medical cannabis in Canada
Access all statistics starting from $2,388 USD yearly *

* For commercial use only

Basic Account

For single users
$0 USD
Always free
Access limited to Free Statistics. Premium Statistics are not included.
  • Free Statistics
Based on your interests

Starter Account

For single users
$199 USD
per month, billed annually 1
Buy now
  • Free Statistics
  • Premium Statistics

    • The statistic on this page is a Premium Statistic and is included in this account.

Professional Account

For teams of up to 5 people
$959 USD
per month, billed annually 1
Buy now
  • Free + Premium Statistics
  • Reports
  • Market Insights

1 All prices do not include sales tax. The account requires an annual contract and will renew after one year to the regular list price.

Compare accounts
Learn more about how Statista can support your business.